[Revised international prognostic scoring system (IPSS-R) for myelodysplastic syndromes]
- PMID: 23823093
[Revised international prognostic scoring system (IPSS-R) for myelodysplastic syndromes]
Similar articles
-
World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes.Br J Haematol. 2007 May;137(3):193-205. doi: 10.1111/j.1365-2141.2007.06537.x. Br J Haematol. 2007. PMID: 17408458
-
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM).Leukemia. 2015 Jul;29(7):1502-13. doi: 10.1038/leu.2015.55. Epub 2015 Feb 27. Leukemia. 2015. PMID: 25721895
-
[Study on prognostic significances of different cytogenetic risk categories in patients with primary myelodysplastic syndromes].Zhonghua Xue Ye Xue Za Zhi. 2011 Dec;32(12):819-24. Zhonghua Xue Ye Xue Za Zhi. 2011. PMID: 22339954 Chinese.
-
Prognostic factors and risk models in myelodysplastic syndromes.Clin Lymphoma Myeloma Leuk. 2013 Sep;13 Suppl 2:S295-9. doi: 10.1016/j.clml.2013.05.022. Clin Lymphoma Myeloma Leuk. 2013. PMID: 24290214 Review.
-
Overview of myelodysplastic syndromes.Semin Hematol. 2012 Oct;49(4):287-94. doi: 10.1053/j.seminhematol.2012.07.002. Semin Hematol. 2012. PMID: 23079058 Review.
Cited by
-
Implications of mutational spectrum in myelodysplastic syndromes based on targeted next-generation sequencing.Oncotarget. 2017 Jul 27;8(47):82475-82490. doi: 10.18632/oncotarget.19628. eCollection 2017 Oct 10. Oncotarget. 2017. PMID: 29137279 Free PMC article.
-
TNF-α, a good or bad factor in hematological diseases?Stem Cell Investig. 2014 Jun 1;1:12. doi: 10.3978/j.issn.2306-9759.2014.04.02. eCollection 2014. Stem Cell Investig. 2014. PMID: 27358858 Free PMC article. Review.
-
GPX3 methylation is associated with hematologic improvement in low-risk myelodysplastic syndrome patients treated with Pai-Neng-Da.J Int Med Res. 2020 Sep;48(9):300060520956894. doi: 10.1177/0300060520956894. J Int Med Res. 2020. PMID: 32967500 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical